drugset / Trial / NCT07226076

Methadone in TKA for Post-op Pain and Opioid Reduction

NCT07226076

Phase 3 Recruiting 162 enrolled Medical University of South Carolina
RandomizedParallel-groupDouble-blindTreatment

Summary

This randomized, double-blind controlled trial investigates whether intraoperative IV methadone (0.15 mg/kg based on ideal body weight) reduces acute postoperative pain and opioid consumption in patients undergoing elective total knee arthroplasty under spinal anesthesia with mepivacaine.

Timeline

Start
2026-01-08
Primary completion
2026-12-28
Completion
2027-01-15

Drugs

EvaluationDrugModalityDoseRoute
Comparator Methadone Other / unclassified 0.15 mg/kg Intravenous

Indications

No indication recorded.